About 568 results

ALLMedicine™ Urinary Free Cortisol Center

Research & Reviews  194 results

Identification of predictive criteria for pathogenic variants of the Primary Bilateral ...
European Journal of Endocrinology; Bouys L, Vaczlavik A et. al.

May 7th, 2022 - Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH) is a heterogeneous disease characterized by adrenal macronodules and variable levels of cortisol excess, with not clearly established clinical diagnostic criteria. It can be caused by ARMC...

The diagnosis and management of Cushing's syndrome in pregnancy.
Journal of Neuroendocrinology; Hamblin R, Coulden A et. al.

May 2nd, 2022 - Endogenous Cushing's syndrome (CS) is rarely encountered during pregnancy. Clinical and biochemical changes in healthy pregnancy overlap with those seen in pregnancy complicated by CS; the diagnosis is therefore challenging and can be delayed. Dur...

Urinary free cortisol and childhood maltreatments in eating disorder patients: New evid...
European Eating Disorders Review : the Journal of the Eat... Meneguzzo P, Mancini C et. al.

Mar 12th, 2022 - Increasing neurobiological evidence has suggested the presence of a specific ecophenotype in people with eating disorders (EDs) linked to early maltreatment. Urinary-free cortisol could strengthen the data and show specific relationships between m...

Performance of DHEAS as a Screening Test for Autonomous Cortisol Secretion in Adrenal I...
The Journal of Clinical Endocrinology and Metabolism; Liu MS, Lou Y et. al.

Feb 10th, 2022 - Autonomous cortisol secretion (ACS) affects up to 30% of patients with adrenal incidentalomas (AIs). The current guidelines for ACS diagnosis are not decisive. A lower dehydroepiandrosterone sulfate (DHEAS) level is a potential biomarker, but the ...

see more →

Drugs  6 results see all →

Clinicaltrials.gov  3 results

Growth Hormone Pretreatment in Poseidon Type IV Undergoing ICSI Using Minimal Induction Protocol: A Randomized Controlled Trial

Oct 22nd, 2021 - Patients are recruited from the attendee of the Infertility clinic and IVF unit in maternity hospital Ain shams university who are eligible for the trial. Procedure will be done by Prof . Dr Mostafa Fouad . and Lecturer Dr Ebtihal ElTaieb * Proper...

The Accuracy of Late Night Urinary Free Cortisol/Creatinine and Hair Cortisol in Cushing's Syndrome Diagnosis

Jan 18th, 2019 - 24h-Urine free cortisol (24h-UFC) and other screening tests may turn out normal in Cushing's syndrome (CS) patients, probably due to high variability and cyclicity in cortisol secretion. To rule out cyclic cortisol secretion, the recommendation is...

Influence of Social and Environmental Factors on Women's Reproductive Function in a Maya Community of Guatemala

Jul 2nd, 2017 - Background & Objectives: To explore the influence that social and environmental factors have on women's reproductive function. The general hypothesis is that deterioration in the quality of women's reproductive environment (e.g. psychosocial stres...

see more →

News  24 results

Heavy Periods Seen in Obesity; T1D Tied to Fracture Risk

Apr 11th, 2021 - Women with obesity may have a higher risk of heavier periods due to delayed endometrial repair. "Although it is difficult to make strong recommendations based on this study alone, a common-sense approach would be to offer weight-loss support to wo...

New Drug Alternative for Cushing's Syndrome?

Oct 4th, 2019 - New phase III clinical trial data suggests that an investigational oral drug, levoketoconazole, might be a useful therapeutic option for patients with Cushing syndrome, the study's authors said. The open-label, non-randomized trial included 94 pat...

Levoketoconazole Offers New Option for Cushing's Syndrome

Apr 26th, 2019 - LOS ANGELES — The investigational cortisol synthesis inhibitor levoketoconazole (Recorlev, Strongbridge Biopharma) is showing promise as an alternative treatment option for endogenous Cushing's syndrome, new data indicate.  Secondary endpoints fro...

Osilodrostat Continues to Show Promise for Cushing's Disease

Mar 25th, 2019 - NEW ORLEANS — The investigational drug osilodrostat (Novartis) continues to show promise for treating Cushing's disease, now with new phase 3 trial data. The data from the phase 3, multicenter, double-blind randomized withdrawal study (LINC-3) of ...

Mysterious Femur Fracture in a Middle-Aged Man

Apr 6th, 2018 - Physical Examination and Workup Upon physical examination, his vital signs are normal. His height is about the same length as his arm span. The patient's physical appearance is remarkable for HIV-treatment–induced lipodystrophy and a Cushingoid ha...

see more →